Game Time: FDA Releases Review Timeline Goals Set By MDUFA V
Executive Summary
This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.
You may also be interested in...
FDA 2024: Watch For Trial-Diversity Guidance, Final Quality Systems Rewrite
Industry observers at RAPS Convergence in Montreal last week said the FDA’s agenda for 2024 is likely to include increased emphasis on MDUFA goals, enhanced cybersecurity requirements, the new QMSR, and more.
It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight
AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.
NAM’S Health Care AI Development Code Of Conduct Addresses Gaps In Current Principles
The National Academy of Medicine developed a code of conduct for health care AI development, as well as commitments for code implementation.